HOME >> BIOLOGY >> NEWS
Case for IBD combination therapy comes from research at Baylor, MIT and Hebrew University

Snowmass, Co. (September 10, 2004) - Inflammatory Bowel Diseases, comprised of Crohn's Disease and ulcerative colitis, are for the most part incurable and their causes are still unknown. About 1 million Americans suffer from IBD and research around the world on new therapeutic strategies against IBD is being reported at a conference sponsored by the American Physiological Society.

On one thing most researchers agree on about IBD: it's very complex. And though it might seem obvious that treating a complex disease might take more than one agent, use of combination therapy hasn't been discussed much in relation to IBD.

Now separate groups working in Houston/Boston and Jerusalem have considered the implications of combination therapy in IBD. They are presenting their papers at the APS conference.

Intestinal Lactobacillus reuteri-based combination therapy directly modulates mucosal pro-inflammatory cytokine production in IL-10 deficient mice.

Probiotics and commensal bacteria represent likely sources for novel therapeutic strategies in inflammatory bowel diseases, and have become increasingly interesting to researchers. Indeed, some probiotic therapy agents are thought to be nearing the clinical trial stage. It is well-known that the human (and animal) gut is full of mostly beneficial bacteria. In IBD and other diseases researchers have taken an approach that reintroduces these positive bacteria, allow them to repopulate the gut and quite often they produce their own anti-inflammatory chemicals. One of the major such "bugs" is the genus Lactobacillus.

The research reported below was carried by James Versalovic and Jeremy Andrew Pena at the Baylor College of Medicine/Texas Children's Hospital, Houston, Texas, and by Arlin B. Rogers, Zhongming Ge and James G. Fox at the Division of Comparative Medicine at Massachusetts Institute of Technology, Cambridge, Mass.

Probiotics have demonstrated efficacy in treating patients
'"/>


10-Sep-2004


Page: 1 2 3

Related biology news :

1. Winning combination to build bone density in children
2. Complex cells likely arose from combination of bacterial and extreme-microbe genomes
3. Researchers zero in on new drug combination strategy
4. IUB researchers to investigate genetic recombinations causes and consequences
5. Mutated protein combination tied to excessive sugar production
6. Clinical study reports findings of combination therapy with DOXIL
7. Novel COX-2 combination treatment may reduce colon cancer risk
8. Drug combination increases life span of mice with ALS
9. A combination of zinc and vitamin A may restore night vision in pregnant Nepalese women
10. Alcohol and thiamine deficiency together: a dangerous combination?
11. Inter-Element Recombination Between Retrotransposons May Be Strategy For Evolution Of Viruses Like HIV

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/30/2020)... ... April 28, 2020 , ... Ever a responsive and ... providing timely and critical information to life science organizations as they navigate the ... concerns. , “Providing the most up-to-date actionable guidance and information has been a ...
(Date:4/28/2020)... ... April 27, 2020 , ... Ofee.com, an ... by three teenagers with an idea to help millions of people during the ... of great need and suffering, an outlet has been created for people to ...
(Date:4/26/2020)... ... April 23, 2020 , ... A team of researchers at the Icahn ... antibody to SARS-CoV-2, the virus that causes coronavirus disease (COVID-19). This antibody is intended ... treatment option for COVID-19. , The efforts are being led by Mone Zaidi, MD, ...
Breaking Biology News(10 mins):
(Date:4/22/2020)... Mich. (PRWEB) , ... April 21, 2020 , ... ... researchers continue their work through COVID-19. Many clinical trial teams are working remotely ... online. Ripple Science wants to help researchers continue their research during this uncertain ...
(Date:4/7/2020)... (PRWEB) , ... April 06, 2020 , ... ... process solutions for the life sciences industry, has announced the release of at-home ... quickly, our top priority is the health and safety of our employees as ...
(Date:4/1/2020)... ... March 31, 2020 , ... ... has developed a method using its revolutionary NEXTGENPCR endpoint thermocycler and consumables ... smaller reaction volumes, increased samples per run, and standard, affordable laboratory equipment, ...
(Date:3/27/2020)... ... March 25, 2020 , ... Enso ... centrally in the midwest for high-quality, quick-turn, board-certified reporting. In an effort ... independent, professional team that is focused on incredible quality, turnaround time and ...
Breaking Biology Technology:
Cached News: